VolitionRx Ltd Issues Shares in Convertible Note Conversions

What Happened
VolitionRx Ltd announced it issued an aggregate of 1,413,450 shares of common stock to Lind Global Asset Management XII LLC to satisfy conversions of its senior secured convertible promissory notes. The Company issued 706,214 shares on September 2, 2026 (to satisfy a $250,000 conversion) and 707,236 shares on September 10, 2026 (to satisfy a $215,000 conversion). These notes were originally issued under a securities purchase agreement dated May 15, 2025 (as amended January 7, 2026).

Key Details

• Total shares issued: 1,413,450 (706,214 on Sept 2, 2026; 707,236 on Sept 10, 2026).
• Conversion amounts: $250,000 and $215,000 (total $465,000) converted into equity.
• Transaction basis: Issuances made to an existing securityholder, no commissions, no public offering, relied on exemptions under the Securities Act (e.g., Section 3(a)(9)/4(a)(2) and/or Rule 506).
• Reported outstanding shares: 27,903,326 common shares outstanding as of September 14, 2026 (the new issuances equal roughly 5.1% of that total).

Why It Matters
For investors, these transactions convert $465,000 of convertible note obligations into equity, reducing the Company’s debt tied to those conversion amounts while increasing shares outstanding by 1.41 million. That increase represents a meaningful one-time dilution (about 5.1% relative to the reported 27.9M shares outstanding) which can affect per‑share metrics and voting percentages. The issuances were private, to an existing holder, and not part of a public offering.